Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma

A Allegra, G Penna, A Alonci, S Russo… - European journal of …, 2013 - Wiley Online Library
Despite recent treatments, such as bortezomib, thalidomide, and lenalidomide, therapy of
multiple myeloma (MM) is limited, and MM remains an incurable disease associated with …

Phage nanofibers in nanomedicine: Biopanning for early diagnosis, targeted therapy, and proteomics analysis

H Xu, B Cao, Y Li, C Mao - Wiley Interdisciplinary Reviews …, 2020 - Wiley Online Library
Display of a peptide or protein of interest on the filamentous phage (also known as
bacteriophage), a biological nanofiber, has opened a new route for disease diagnosis and …

Production of nanobodies against prostate-specific membrane antigen (PSMA) recognizing LnCaP cells

H Zare, M Rajabibazl, I Rasooli… - … journal of biological …, 2014 - journals.sagepub.com
Prostate cancer is the most common type of cancer in men. The antibody-mediated therapy
for cancer treatment depends on the identification of selected molecular targets. The …

[HTML][HTML] Chromosomal instability and acquired drug resistance in multiple myeloma

W Wang, Y Zhang, R Chen, Z Tian, Y Zhai, S Janz… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Chromosomal instability (CIN) is an important hallmark of human cancer. CIN not only
contributes to all stages of tumor development (initiation, promotion and progression) but …

Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display

K Even-Desrumeaux, D Nevoltris, MN Lavaut… - Molecular & Cellular …, 2014 - ASBMB
Phage display is a well-established procedure to isolate binders against a wide variety of
antigens that can be performed on purified antigens, but also on intact cells. As selection …

Development of a novel human scFv against EGFR L2 domain by phage display technology

L Rahbarnia, S Farajnia, H Babaei… - Current …, 2017 - ingentaconnect.com
Epidermal growth factor receptor (EGFR) as a transmembrane tyrosine kinase receptor
frequently overexpresses in tumors with epithelial origin. The L2 domain from extracellular …

Methods for selecting binders by phage display and masked selection

D Baty, P Chames - US Patent App. 16/392,794, 2019 - Google Patents
The present invention relates to methods for selecting binders by phage display and masked
selection. More particularly, the present invention relates to a method for selecting a plurality …

Methods for selecting binders by phage display and masked selection

D Baty, P Chames - US Patent 10,316,315, 2019 - Google Patents
The present invention relates to methods for selecting binders by phage display and masked
selection. More particularly, the present invention relates to a method for selecting a plurality …

Methods for selecting binders by phage display and masked selection

D Baty, P Chames - US Patent 9,605,257, 2017 - Google Patents
The present invention relates to methods for selecting binders by phage display and masked
selection. More particularly, the present invention relates to a method for selecting a plurality …

[PDF][PDF] Generation of recombinant antibody fragments specific formurine mesangial cells: functionalization of highly specific fusion proteins for diagnostic approaches …

P Bogner - 2015 - core.ac.uk
The physiologic inner milieu of the vertebrate's organism has to be permanently adapted to
its outer environment. The kidneys thereby play a major role. These two vital organs play a …